trending Market Intelligence /marketintelligence/en/news-insights/trending/UefailXRvg7bnZ1_zvxCnw2 content esgSubNav
In This List

Crescita subsidiary acquires skincare line from Sanofi

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Crescita subsidiary acquires skincare line from Sanofi

A wholly-owned subsidiary of Crescita Therapeutics Inc. acquired the Alyria skincare line from Sanofi Consumer Health Inc.

The product line, which is sold into medical spas, will complement INTEGA Skin Sciences' Pro-Derm product offering.

Crescita will pay $1.7 million in cash for the product line and pay a royalty over a nine-year period starting in 2020.

Sanofi Consumer Health is a Sanofi unit.